Kiniksa Pharmaceuticals International Plc (KNSA)
58.60
+1.67
(+2.93%)
USD |
NASDAQ |
May 08, 16:00
58.54
-0.06
(-0.10%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Market Cap : 4.509B for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals, Inc. | 1.959B |
| Amgen, Inc. | 179.12B |
| Savara, Inc. | 1.070B |
| BioMarin Pharmaceutical, Inc. | 10.45B |
| United Therapeutics Corp. | 23.98B |
Market Cap Related Metrics
| PE Ratio | 64.59 |
| PS Ratio | 6.255 |
| Price to Book Value | 7.444 |
| Price to Free Cash Flow | 28.72 |
| Price | 58.60 |
| Earnings Yield | 1.55% |
| Operating PE Ratio | 50.60 |
| Normalized PE Ratio | 64.59 |